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Sleep disorders in attention-deficit
hyperactivity disorder and autism
spectrum disorder: a pragmatic
approach to assessment
and management
Paul J. Shanahan , Miriam Isaac & Jane E. Blackwell
SUMMARY
Sleep is essential for survival and humans spend
approximately one-third of their life asleep.
Adequate sleep is needed to maintain both phys-
ical and psychological health. Routinely getting
less than the recommended amount of sleep for
your age can have profound negative effects on
health, such as increasing the likeliness of psychi-
atric illness, diabetes, cardiovascular disease and
stroke. In children and adults with neurodevelop-
mental disorders, the prevalence of sleep disor-
ders is significantly higher than in the general
population. Given the relationship between sleep
and psychiatric disorders, it is essential that
psychiatrists have knowledge of the principles of
sleep medicine. In this article, we focus on
the common sleep disorders found in those
with attention-deficit hyperactivity disorder
(ADHD) and autism spectrum disorder (ASD) and
give an overview of screening, diagnosis and
management.
LEARNING OBJECTIVES
After reading this article you will be able to:
• recognise the common coexisting sleep disor-
ders in individuals with ASD and ADHD
• develop a working knowledge of sleep disorders
that may be encountered in psychiatric practice
(with particular focus on individuals with ADHD
and ASD)
• demonstrate a broad understanding of how
sleep disorders are investigated and treated in
children, adolescents and adults with ADHD and
ASD.
KEYWORDS
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Fundamentals of normal sleep
Sleep is a fundamental biological function and on
average we spend about one-third of our life asleep
(Stores 2009). Disruptions to a restorative sleep
can affect an individual’s neurocognition, mood
and daytime functioning (Wajszilber 2018). Long-
term sleep disturbance can result in broad health
consequences, including coronary heart disease,
stroke, inflammatory disease and increased
likelihood of type 2 diabetes onset (Cappuccio
2010, 2011; Irwin 2016).
Normal sleep and wakefulness
There are two types of sleep: non-rapid eye move-
ment (NREM) and rapid eye movement (REM)
sleep. The stages of sleep are characterised by differ-
ent patterns of brain activity, eye movements and
muscle tone. The basic structure of sleep is referred
to as ‘sleep architecture’ and can be represented
using a hypnogram (Fig. 1). Typical overnight
sleep usually begins with NREM sleep and then
follows a cyclical pattern alternating between
NREM and REM sleep phases, with brief wakings
every 90 min until the person wakes up.
The sleep–wake cycle is one of the circadian
rhythms and runs roughly every 24 h. These
rhythms are generated by the suprachiasmatic
nucleus in the hypothalamus, which functions as a
biological clock (Dunlap 2004). The sleep–wake
system is thought to be regulated by two major pro-
cesses, one that drives sleep (process S) and one that
maintains wakefulness (process C) (Gillette 2005).
The need for sleep (process S) accumulates across
the day, peaking just before bedtime. This homeo-
static drive for sleep is reduced following adequate
rest at night and the circadian waking drive
(process C) begins to increase, and then the cycle
starts again.
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As shown in Fig. 2, there are normal variations
with age in how sleep is initiated and maintained,
the percentage of time spent in each stage of sleep
and overall sleep efficiency (Altevogt 2006).
Restorative sleep is important in learning,memory
and affect regulation. Sleep deprivation has been
shown to have a negative impact on learning, and
research suggests that sleep has an important role
in regulating the synaptic plasticity and connectivity
of the brain. Together with impairments of attention
and alertness, sleep deprivation is commonly asso-
ciated with increased subjective reports of irritability
and mood changes (Walker 2009).
Diagnostic classification of sleep disorders
The International Classification of Sleep Disorders,
now in its third edition (ICSD-3), can be used to
diagnose insomnia, sleep-related breathing disor-
ders, central disorders of hypersomnolence,
circadian rhythm sleep–wake disorders, parasom-
nias and sleep-related movement disorders such as
restless legs syndrome, periodic limb movement dis-
order and sleep-related leg cramps (American
Academy of Sleep Medicine 2014).
The two most commonly reported sleep disorders
in individuals with attention-deficit hyperactivity
disorder (ADHD) or autism spectrum disorder
(ASD) are insomnia and circadian rhythm sleep–
wake disorders (ICD-10 and DSM-5 ‘circadian
rhythm sleep disorders NOS’). Insomnia is difficulty
getting to sleep or staying asleep despite having
opportunity and circumstances to sleep, leading to
unsatisfactory sleep or daytime consequences
(American Academy of Sleep Medicine 2014;
Selsick 2018). To be classified as having insomnia
the individual must present with these difficulties
for at least 3 months and the problems must occur
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FIG 1 Progression of sleep states across a single night in a young adult. REM, rapid eye movement (Carskadon 2005). © 2006
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FIG 2 Changes in sleep with age. WASO, wake time after sleep onset; REM, rapid eye movement; SWS, slow-wave sleep
(Carskadon 2005). © 2006 National Academy of Sciences: reproduced with permission of Elsevier.
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Circadian rhythm sleep–wake disorders are
defined by ISCD-3 as ‘a chronic or recurrent
pattern of sleep–wake rhythm disruption primarily
caused by an alteration in the circadian timing
system or misalignment between the circadian
rhythm and the sleep–wake schedule desired or
required causing a sleep–wake disturbance
(ie, insomnia or excessive sleepiness, and associated
distress or impairment)’ (American Academy of
Sleep Medicine 2014). For all circadian rhythm
sleep–wake disorders, with the exception of jet lag
disorder, a duration criterion of at least 3 months
is specified by ISCD-3.
Sleep and its relationship to psychiatric disorders
It is estimated that 40% of people diagnosed with
insomnia have a coexisting psychiatric condition
(Anderson 2013). A common symptom in the ICD-
10 diagnosis of a depressive episode is disturbed
sleep, and epidemiological studies have found a
50–90% comorbidity between depression and poor
sleep quality (Anderson 2013). Additionally, those
who have obstructive sleep apnoea are likely to
experience depressive symptoms (BaHammam
2016). ICD-10 guidelines indicate that when psychi-
atric disorders co-occur with insomnia, both diagno-
ses should be given (World Health Organization
1992). In the treatment of depression, if there is a
comorbid sleep disorder, the greatest risk factor for
relapse is the presence of an ongoing untreated
sleep disorder (Fang 2018). Other common psychi-
atric disorders co-occurring with sleep disorders
include schizophrenia (30–80%) and bipolar dis-
order (17–57%) (Anderson 2013).
Sleep disorders are common in children with
Tourette syndrome or chronic tic disorder, obsessive
compulsions, anxiety, ADHDandASD. A systematic
review reported that sleep difficulties occur in 9.7–
80.4% of children with Tourette syndrome/chronic
tic disorder, with co-occurring anxiety increasing the
risk of sleep disorders (Hibberd 2020).
Early evidence suggests that mental disorders
improve when interventions for sleep disorders are
provided. The SENSE study was a randomised con-
trolled trial including 144 adolescents (12–17 years)
with high levels of anxiety and sleeping difficulties
without a past or current depressive disorder
(Blake 2016). Following a cognitive–behavioural/
mindfulness-based intervention for sleep disturb-
ance, improvements were noted on subjective and
objective sleep measures and in anxiety symptoms
(Blake 2016). OASIS, a randomised controlled
trial of cognitive–behavioural therapy (CBT) for
insomnia involving 3755 university students
resulted in a reduction in paranoia and hallucinatory
experiences (Freeman 2017).
Autism spectrum disorder
Autism spectrum disorder (ASD) is a behaviourally
diagnosed neurodevelopmental disorder with quali-
tative differences in three domains. The domains
remain similar across DSM-5 (American
Psychiatric Association 2013) and ICD-10 (World
Health Organization 1992), and they include recip-
rocal social interaction, social communication and
restricted, repetitive behaviour or interests. Despite
the use of differing language across ICD-10 and
DSM-5, the core characteristics remain the same.
Severity of symptoms, comorbid intellectual impair-
ment and daily functioning often dictate the terms
used to describe ASD. Currently, childhood
autism, atypical autism and Asperger syndrome
exist in ICD-10, but the use of these terms is starting
to reduce in clinical practice. Current clinical prac-
tice reflects DSM-5 diagnosing of all of these presen-
tations as ‘autism spectrum disorder’. The estimated
prevalence of ASD in children is 2.24–3.2%, with an
increasing trend in cumulative incidence since 1992
(Zablotsky 2015; Saito 2020).
Diagnosis of sleep disorders in people with ASD
The prevalence of sleep disorders in ASD is 50–
80% in adults and 40–80% in children (Charrier
2017; Papadopoulos 2019). There are various
hypotheses regarding intrinsic and extrinsic causes
for the high prevalence of insomnia in individuals
with ASD (Souders 2017). These include neurobio-
logical, medical, behavioural and cultural mechan-
isms, and the cause in any given individual is
likely to be multifactorial (Souders 2017). The
prevalence of sleep disorders in ASD may be mis-
leading owing to the lack of consensus regarding
their definition (Richdale 2009). The need to
assess sleep in those with ASD is highlighted in
primary care prescribing. A study of prescribing
practices in the UK found that the most commonly
prescribed medication (including melatonin) for
individuals with ASD is for sleep, and even then
rates were low (9.7% of the cohort) (Murray 2014).
Insomnia is particularly prevalent in children with
ASD, resulting in increasing severity of ASD symp-
toms (Veatch 2017). Children’s sleep difficulties
can have an impact on the family, affecting
parents’ sleep and mood and resulting in fatigue
and strain on relationships. A comparison of sleep
patterns between parents of neurotypical children
and those with ASD identified reduced sleep
quality and quantity in the latter group (Meltzer
2008).
It has been suggested that, for some children with
ASD, sleep disorders occur as a result of inappropri-
ate sleep-related behaviours and parental misman-
agement (Wiggs 2004). In adults with ASD,
Shanahan et al
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objective evaluation of sleep measures indicates
longer sleep onset latency and shorter sleep duration
compared with neurotypical controls. Furthermore,
some circadian rhythm sleep–wake disorders are
significantly more likely in people with ASD than
in the general population (Baker 2017). Finally. it
is worth noting that parasomnias are more
common in children with ASD (Ming 2009).
Diagnosis of the various sleep disorders in indivi-
duals with ASD can be difficult for a number of
reasons. First, given that ASD is a social communi-
cation disorder, those who experience sleep disor-
ders, irrespective of intellectual impairment, do not
often spontaneously report sleep as a problem
(Limoges 2013). Despite this, actigraphy data and
subjective reporting (when explicitly asked) indicate
that those with ASD experience lower rates of sleep
efficiency and increased duration of sleep onset
latency (Morgan 2020). Second, currently there are
no validated screening tools specific to the sleep dis-
orders experienced by those with ASD. A caution for
the use of screening tools in specialist populations is
that they may be misleading because they do not
accurately capturing the appropriate sleep disorders
relevant to that particular patient group (Faulkner
2019). Clinicians may need to take this into consid-
eration when solely relying on screening tools for
assessment or onward referral.
Relationship between ASD, sleep and psychiatric
disorders
The lifetime prevalence estimates for an anxiety dis-
order or a depressive disorder in people with ASD
are 27–43% and 23–37% respectively, which are
higher than the general population (Hollocks
2019). Evidence indicates that, when sleep is
improved in ASD, there are reported improvements
in anxiety and depression (Loring 2018). Rates of
obsessive–compulsive disorder in individuals with
ASD were also significantly higher than in the
general population, at 22–24% (Hollocks 2019).
Attention-deficit hyperactivity disorder
Attention deficit hyperactivity disorder (ADHD) is
characterised by the core symptoms of inattention,
hyperactivity and impulsivity. There are two main
sets of diagnostic criteria in current use: ICD-10
and DSM-5. Both ICD-10 and DSM-5 require
6-month duration of symptoms (National Institute
for Health and Care Excellence 2018). The diagnos-
tic criteria for ADHD have been updated in DSM-5
to capture more accurately the experience of adults
affected by the disorder. DSM-5 states that this revi-
sion is based on nearly two decades of research
showing that ADHD, although a disorder that
begins in childhood, can continue through
adulthood for some people (American Psychiatric
Association 2013).
There is no separate diagnostic criteria for adults
with ADHD in ICD-10. A diagnosis of hyperkinetic
disorder may also be made in adult life using the
same criteria as in children, although attention and
activity must be judged with reference to develop-
mentally appropriate norms (World Health
Organization 1992).
Diagnosis of sleep disorders in people with ADHD
Sleep problems are reported in an estimated 25–50%
of individuals who have ADHD (Corkum 1998).
A systematic review of sleep disorders in adolescents
with ADHD identified overall association between
sleep disorders and poorer outcomes in clinical,
cognitive and functional domains (Lunsford-Avery
2016). Comorbidities in ADHD such as circadian
rhythm sleep–wake disorders, sleep-related
breathing disorders, narcolepsy and insomnia are
often missed and left untreated. A review by
Konofal et al (2010) reported that up to 44% of
those with ADHD had restless legs syndrome, but
the authors advised caution in interpreting this
finding owing to the methodological limitations
identified in the studies. However, this may be
relevant from a clinical evaluation point of view.
More studies are needed to understand the
prevalence and underlying pathways of symptoms
of restless legs syndrome in those with ADHD.
Poor sleep hygiene, disrupted routine and impulse
control difficulties may affect the ability of an indi-
vidual with ADHD to have a winding-down
period, leading to bedtime resistance and delayed
sleep onset. Delayed sleep–wake phase disorder
and late chronotype are frequently comorbid with
ADHD in both adults and adolescents (Kooij
2013; Sivertsen 2014). There are proposals suggest-
ing that people with ADHD may have stronger
delayed circadian preference and a possible
delayed release of endogenous melatonin (Gruber
2012).
In ADHD, insomnia is reported to be more fre-
quent among children (73.3%) (Sung 2008) than
among adults (66.8%) (Brevik 2017). These rates
are higher than insomnia estimates in children
(20–30%) (Calhoun 2014) and adults (6–50%)
(Ohayon 2002) in the general population. Women
with ADHD reported higher prevalence of insomnia
than women without ADHD (43.9 v. 12.2%)
(Fuller-Thomson 2016). Recent studies indicate
that over 30% of individuals with narcolepsy,
which is characterised by excessive daytime sleepi-
ness and cataplexy, have comorbid ADHD (Kim
2020). A history of snoring or possible obstructive
sleep apnoea during childhood is associated with a
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twofold difference in the odds of ADHD diagnosis or
symptoms (Constantin 2014). Other psychopatholo-
gies, such as anxiety, depression and tic disorders,
are common in those with ADHD, and we recom-
mend that a systematic assessment of coexisting
conditions be carried out when evaluating for sleep
disorders in those with ADHD.
The relationship between ADHD and ASD
Considerable overlap exists between ASD and other
mental disorders. ADHD, anxiety disorders, depres-
sion, conduct disorder and behaviours that chal-
lenge are among the disorders most commonly
associated with ASD (Matson 2013). DSM-5
permits a dual diagnosis of both ADHD and ASD.
An estimated 30–80% of children with ASD also
meet the criteria for ADHD and, conversely,
20–50% of children with ADHD meet criteria for
ASD. Given this overlap, more research is needed
to further understand the relationship between the
two conditions. It is important that clinicians are
aware of the conditions likely to co-occur with
ASD, which vary according to the person’s age.
Clinicians should also be familiar with the assess-
ment methods that are available to assist in diagno-
sis and keep up to date with new research in this area
(Matson 2013).
Assessment and diagnosis
Before assessing for a sleep disorder, the clinician
should consider predisposing, precipitating and per-
petuating factors that cause sleep disturbance. An
example is gastrointestinal disorders, which are
commonly associated with sleep problems in indivi-
duals with ASD (Klukowski 2015). Additionally,
behaviours that challenge may need considering as
a cause of the sleep disorder and can be measured
using an appropriate screening tool. The first step
in assessing a sleep disorder in children and adults
with ASD and ADHD is taking a detailed sleep
history. There are a range of factors to consider, out-
lined in Table 1.
Taking a detailed history may highlight factors
that clearly indicate environmental or iatrogenic
impact on sleep. The flowchart shown in Fig. 3 can
be followed to inform the decision to diagnose or
move to a specialist referral.
Screening tools
Box 1 lists frequently used questionnaires for
screening for clinically significant sleep problems.
These tools can be found online and some are avail-
able to use for clinical and research purposes free of
charge.
Specialist sleep services
In some cases, it may be necessary to refer indivi-
duals with ASD or ADHD for assessment at a spe-
cialist centre. Sleep centres in the UK can be
located through the National Health Service’s
‘Find Sleep Medicine Services’ webpage (www.nhs.
uk/service-search/other-services/Sleep-Medicine/
LocationSearch/1888). As a rule of thumb, any new
onset of parasomnia should trigger further evalu-
ation by a specialist. Table 2 provides an overview
of the signs and symptoms that indicate that referral
to a specialist centre may be necessary.
Diagnosis of a sleep disorder Typically, specialist
services will identify and diagnose a sleep disorder
by taking a detailed history (especially about the
sleep problem), performing a physical and behav-
ioural examination, and monitoring the 24 h
sleep–wake pattern using a sleep diary and possibly
objective sleep studies such as actigraphy or poly-
somnography (Stores 2015). Information about
family circumstances and history will also be
TABLE 1 Sleep assessment
Sleep history Nature of the sleep disturbance Additional factors to consider
• Onset of the problem (acute or chronic)
• Duration of the problem
• Severity (subjective and objective)
• Is the problem constant or episodic?
• Impact on behaviour, mood, cognitive
functioning, academic progression
• Developmental appropriateness of the
problem
• Comorbidities (physical and
mental illness)
• Family history
• Is it iatrogenic? (medications that
cause sleep impairments)
• Family/carer expectations
• Sleep onset latency (difficulty falling
asleep)
• Sleep duration (time in bed and time
sleeping)
• Number and duration of night-time
awakenings
• Morning wake time
• Changes in sleep time
• Daytime napping or sleepiness
• Restlessness, particularly legs
• Nightmares
• Unusual or bizarre behaviour at night
(include night terrors and sleep paralysis)
• Breathing difficulties or snoring (noted by
partner or carers)
• Diet and timing of food (include caffeine,
allergies)
• Alcohol and illicit substance intake
• Travel, jet lag and shift working
• Sleep-interfering behaviour (routines,
telephone use, playing in bed, stereotypy)
• Sleeping environment (other people, noise,
lights, temperature, bed comfort, odour,
humidity)
• Anxiety and current stressors
• What has the person tried or is currently
trying to resolve the problem?
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sought. For children, parenting practices and the
child’s development history will be assessed.
Figure 4 outlines patterns observed in common cir-
cadian rhythm sleep–wake disorders.
Treatment options
One of the problems noted in the literature is the use
of an array of terminologies to describe sleep symp-
toms, such as sleep disturbance, sleep difficulties
and sleep disorders. Making a clear distinction
between them will be useful in clinical practice.
Aspects of sleep should be carefully assessed before
starting treatment or medication. This requires the
clinician to use structured assessments and evalu-
ation tools, which will help them to understand the
baseline state and choose a suitable treatment
option.
Non-pharmacological interventions
In the management of insomnia and circadian
rhythm sleep–wake disorders in individuals with
ADHD or ASD, lifestyle factors, including exercise
and diet, should be considered, followed by consid-
eration of strategies to ensure adherence to treat-
ment plans (National Institute for Health and Care
Excellence 2018). The use of personalised remin-
ders, incentives and clearly documented instructions
may help (Hauck 2016). Social Stories™ (Kokina
2010) and visual schedules (Malow 2014) have
shown good short-term effectiveness in reducing
behaviours that challenge related to bedtime rou-
tines and facilitating interventions such as the
bedtime pass programme for children.
Interventions for children with ASD primarily
focus on education of parents and carers (Johnson
Screening for sleep disorders in
 ADHD and ASD 
Assessment
 Comprehensive clinical history, 
onset, nature, duration, frequency 
and impact of the sleep-related
symptoms
Contributing factors:mental
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FIG 3 Flowchart for the assessment of sleep disorders. ADHD, attention-deficit hyperactivity disorder; ASD, autism spectrum
disorder; GP, general practitioner; PSQi, Pittsburgh Sleep Quality Index; CHSQ, Children’s Sleep Habits Questionnaire;
CBT, cognitive–behavioural therapy.
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2013). Training programmes include providing
information about normal sleep, recommendations
for establishing good stimulus control in the
bedroom environment, sleep scheduling and man-
aging maladaptive behaviour at night-time
(Johnson 2013). Providing two educational sessions
covering sleep hygiene and relaxation strategies to
adolescents with ASD and their carers resulted in
improvements in sleep latency and efficiency
(Loring 2018). In all interventions outlined above,
homework tasks are set and reviewed at subsequent
sessions (Cortesi 2012; Loring 2018). Online parent
training has also shown promising short-term sleep
improvements in children with ASD (Roberts 2019).
Sleep hygiene is a term used widely in sleep disor-
ders, but it will look different for each patient. It
focuses on the principles of stimulus control and
nurturing bodily changes to encourage sleep
during natural cycles. Stimulus control refers to
ensuring that the place of sleep is associated with
sleeping and other places are associated with wake-
fulness. An example of an intervention to promote
stimulus control among adolescents or adults is
leaving the bedroom after 15 min if not sleeping
and then returning to bed only when tired. Any
non-sleep-related behaviours that occur in bed (e.g.
laptop use, video games or watching TV) should be
relocated to other living areas where possible.
In adults with ASD and ADHD, as circadian
rhythm sleep–wake disorders are more common,
the use of light therapy has shown effectiveness,
involving 10 000 lux light to promote wakefulness
and 400 lux dim red light prior to sleep onset. In
advanced sleep–wake phase disorder, 10 000 lux
can be considered between 18.00 and 21.00 h; for
delayed sleep–wake phase disorder 10 000 lux can
be considered between 10.00 and 13.00 h; and for
irregular sleep–wake disorder 10 000 lux at 09.00 h
for 30 minutes might be used (Burgess 2016).
There is growing evidence for the use of CBT for
insomnia (CBT-I) face to face or online (National
Institute for Health and Care Excellence 2017).
A consideration that might affect the likelihood of
behaviour change in individuals with ASD or
ADHD is the extent to which restricted and repetitive
behaviours affect daily living and sleep routines.
Finally, sleep disorders are highly associated with
daytimedistress andmaladaptive behaviours in indi-
viduals with ASD (Abel 2018). In adults as well as
children with a diagnosis of ASD, a functional
analysis of behaviours that challenge followed by a
function-based intervention plan is recommended
(National Institute for Health and Care Excellence
2012). If a functional analysis is not feasible, other
functional assessment procedures can be used
aiming to understand the relationship between the
maladaptive behaviour and its maintaining conse-
quences. In adults, who are very likely to be able to
describe the contingencies, this may be sufficient to
understand maintaining consequences.
A recent systematic review of non-pharmaco-
logical interventions for non-respiratory sleep disor-
ders in children with neurodisabilities (including
ASD and ADHD) identified that, despite clinical
guidance recommending parent-directed interven-
tions as the first approach to managing sleep disor-
ders, there is a lack of high-quality evidence
assessing the effectiveness of non-pharmacological
interventions for these populations (Scantlebury
2018). Given the limitations of the existing evidence,
BOX 1 Commonly used screening questionnaires for clinically significant sleep problems
For children and adolescents
• Bespoke sleep diary (1 week minimum).
• Sleep Disturbance Index (SDI): a four-item, parent-rated
questionnaire that covers settling problems, night waking
and parental involvement at night.
• Children’s Sleep Habits Questionnaire (CSHQ): a 45-item,
parent-rated questionnaire that assesses the frequency of
behaviours associated with common paediatric sleep
disorders.
• Paediatric Daytime Sleepiness Scale (PDSS): self-report
questionnaire designed to assess sleepiness in 11- to 15-
year-olds.
For adults
• Bespoke sleep diary (1 week minimum).
• Epworth Sleepiness Scale (ESS): a self-administered ques-
tionnaire with eight questions. Respondents are asked to
rate, on a four-point scale (0–3), their usual chances of dozing
off or falling asleepwhile engaged in eight different activities.
• Pittsburgh Sleep Quality Index (PSQI): a self-report question-
naire that assesses sleep quality over a 1-month period.
• STOP-Bang Questionnaire: an eight-item questionnaire that
determines risk for sleep apnoea. It is one of the most
widely accepted screening tools for obstructive sleep
apnoea.
• Morningness–Eveningness Questionnaire (MEQ): a self-
assessment questionnaire to measure whether a person’s
circadian rhythm (biological clock) produces peak alertness
in the morning, in the evening or in between.
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the authors highlighted the importance of prioritis-
ing research in this area.
Pharmacological interventions
From a clinical perspective when prescribing, thor-
ough consideration must be given to predisposing,
precipitating and perpetuating factors and differen-
tial diagnosis. Some psychiatric drugs have insom-
nia as a side-effect or even unmask a subclinical
REM sleep behaviour disorder. If there are under-
lying coexisting mental illnesses such as anxiety or
depression, the choice of medication with sedative
effects may be worth considering, but not as a
stand-alone treatment for sleep disorders.
Stimulants are the first-line medication for treat-
ment of ADHD. The effects of stimulant medication
on sleep in those with ADHD vary, which may be a
reflection of the underlying complexity of the link
between ADHD and sleep disorders (Graham
2011). Stimulants are associated with disturbed
sleep, such as increased sleep onset latency, difficul-
ties falling asleep and decreased total sleep time in
those with ADHD (Stein 2012). However, some
studies have also shown that ADHD symptom
control can promote sleep (Jerome 2001).
Adjusting the dose or changing to another formula-
tion have all been proposed (Konofal 2010). In con-
trast to stimulants, the most common side-effect
associated with atomoxetine and guanfacine is som-
nolence. Dosing in the evening rather than in the
morning has been found to reduce daytime somno-
lence with atomoxetine (Block 2009).
Medications can be effective in treating circadian
rhythm sleep–wake disorders and insomnia.
Melatonin has been shown to reduce the symptoms
TABLE 2 Referral to specialist sleep services
Sleep disturbance/
disorder Description
Signs and symptoms that indicate referral to a
specialist centre may be necessary
Nightmares Repeated occurrences of extended, extremely
dysphoric and well-remembered dreams that
usually involve threats to survival, security or
physical integrity
May require further investigation if there are
unusual features such as drooling, stiffening,
jerking, repetitive screaming, kicking or
thrashing. Referral may also be necessary if
there is a history of significant head injury
Sleep-walking or night
terrors
Undesirable physical events or experiences that
occur during the initiation of sleep, during sleep
or during arousal from sleep
May require further investigation if the onset is
during adolescence, as this may indicate an
underlying medical or psychological problem.
Also refer if the individual is a danger to
themselves or others or if the episodes cause
significant disruption or distress
Sleep apnoea Temporary cessation of breathing during sleep.
Sleep-related breathing disorders are divided
into four sections: obstructive sleep apnoea,
central sleep apnoea syndromes, sleep-related
hypoventilation disorders, and sleep-related
hypoxaemia disorder
Consider referral if there are concerns about
breathing difficulties, excessive daytime
tiredness or sleep disturbance with snoring.
Refer or liaise with general practitioner if there
are red flags on the STOP-Bang questionnaire.
Also refer if blue lips (cyanosis) have been
reported by parents or carers
Bruxism Involuntary habitual grinding of the teeth, typically
during sleep
Refer if there are concerns about underlying stress
or a dental problem
Narcolepsy Chronic neurological sleep disorder characterised by
excessive daytime sleepiness, cataplexy (loss of
muscle tone) and disturbed night-time sleep
Refer if the following features are reported:
excessive daytime sleepiness (EDS), which can
be assessed using the Epworth Sleepiness
Scale (score of >10 indicates EDS and >17
indicates severe EDS), cataplexy features,
hallucinations, weight gain, sleep paralysis
Movement disorders Leg movement disorders and rhythmic movement
disorders (as listed below)
Refer if causing disturbance to sleep, family life or if
there is a suggestion of an underlying medical
trigger
Restless legs syndrome Also known as Willis–Ekbom disease: a common
condition of the nervous system that causes an
overwhelming irresistible urge to move the legs




Repetitive cramping or jerking of the legs during
sleep





Sleep-related rhythmic movement disorder involving
repeated body movements
More common in autism spectrum disorder. Refer if
there are concerns about possible abuse, as





Dream re-enactment behaviour during REM sleep
that can result in injury to self and others
Refer to a specialist sleep clinic. Also, consider
iatrogenic effects of tricyclic antidepressants,
monoamine oxidase inhibitors and selective
serotonin reuptake inhibitors
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related to insomnia, to improve sleep latency and
improve sleep efficiency and total sleep duration
(Jenabi 2019). This observation was replicated in a
systematic review of pharmacological treatments for
sleep disorders in children, which concluded that
melatonin was useful in improving sleep latency,
sleep duration and wake time after sleep onset at
least in the short term, particularly with children
with comorbid ASD and other neurodevelopmental
disorders (McDonagh 2019). However, there was
no improvement noted in the number of awakenings
per night withmelatonin.More research is required to
establish how andwhen to stopmelatonin use in indi-
viduals with neurodevelopmental disorders. Utilising
melatonin should be considered with caution as it is
not currently licensed in the UK for use in adults
between 18 and 55 years of age (National Institute
for Health and Care Excellence 2015).
Hypnotics are effective in treatment of insomnia,
however they are for short-term use and only work
for as long as they are used (Riemann 2009).
Short-acting hypnotics may be helpful for sleep-
onset insomnia. In theUK, hypnotics for themanage-
ment of insomnia are only licensed for short-term
use. Clinicians should consider the risk of side-
effects, including dependency, cognitive impairment,
falls and withdrawal symptoms. NICE guidance sug-
gests only to use hypnotics if insomnia is severe and
to use the lowest possible dose for the shortest period
of time (National Institute for Health and Care
Excellence 2015). Insomnia can be a chronic condi-
tion, so behavioural interventions and CBT-I are sug-
gested as treatment choices (Riemann 2009).
Neurodevelopmental disorders and sleep
disorders in intellectual disabilities
For individuals with intellectual disabilities, there is
a fourfold higher likelihood of having ADHD than
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FIG 4 Circadian rhythm sleep–wake disorders (CRSWD) (Takaesu 2016). © 2016 Takaesu et al: reproduced under the terms of
the Creative Commons Attribution License (CC BY 4.0).
Shanahan et al
328 BJPsych Advances (2021), vol. 27, 320–332 doi: 10.1192/bja.2020.65
Downloaded from https://www.cambridge.org/core. 07 Jan 2022 at 15:45:24, subject to the Cambridge Core terms of use.
an even greater likelihood of having a comorbid
diagnosis of ASD. The prevalence of sleep disorders
among people with intellectual disabilities is high
and increased further in populations with specific
chromosomal disorders (Boyle 2010).
Sleep disorders in this population can present as
behaviours that challenge and are associated with
poor quality of life for the patient and caregivers
(Lenjavi 2010). Current guidance for adults with
intellectual disabilities highlights the completion of
a functional analysis prior to the use of melatonin
(National Institute for Health and Care Excellence
2015). However, there is no evidence for the use of
functional analysis in identifying or assessing
sleep-related behaviours that challenge and, as men-
tioned above, melatonin only has a licence for those
under 18 and over 55 (National Institute for Health
and Care Excellence 2015). Before assessment for a
sleep disorder, a comprehensive assessment of phys-
ical health, including review of current medications
and epilepsy management, may be needed.
A systematic review of interventions for sleep dif-
ficulties, including sleep hygiene, behavioural inter-
ventions and use of melatonin, found that existing
literature is of low quality (Shanahan 2019).
However, there is some evidence that educating
parents about interventions such as stimulus
control and other sleep-related behaviours improves
sleep in children and should be considered for
parents and carers of adults with ASD and comorbid
intellectual disabilities.
Clinical implications and future directions
Children and adults presenting with neurodevelop-
mental disorders should be offered assessment for
primary sleep disorders which may need separate
treatment strategies. The problems of circadian
rhythm sleep–wake disorders and insomnia can
persist into adulthood if not treated. The focus ques-
tions outlined in Table 1 may assist in taking the
clinical history. Baseline records of sleep onset
latency, night-to-night variability and total sleep
duration before treatment begins will be helpful to
evaluate progress and formulation of a management
plan. Most intervention plans should include psy-
choeducation and behavioural interventions such
as sleep hygiene. Sleep studies may be required for
those with new or complex sleep disorders.
Clinicians may face additional challenges on con-
tinued prescriptions of melatonin. Shared-care treat-
ment protocols and transition meetings between
children’s and adult services or primary care physi-
cians may be required.
A diagnosis of chronic insomnia disorder should
only be considered when the insomnia is especially
prominent or unexpectedly prolonged and is the
focus of clinical assessment and treatment. In such
cases, care is best offered in consultation with sleep
clinics.
Behavioural interventions should be considered
for long-term sleep disorders. One such is CBT for
insomnia (CBT-I), an evidence-based effective treat-
ment for insomnia in those with comorbid psychi-
atric illness (Taylor 2014). There are several web-
based apps available, such as Sleepio, Headspace
and Calm, which incorporate aspects of CBT,
relaxation, meditation and mindfulness. There is
insufficient evidence supporting the use of apps
such as Sleepio, Headspace and Calm in this popula-
tion and there are risks of high drop-out rates
(Freeman 2017; National Institute for Health and
Care Excellence 2017). More research into the effect-
iveness of online CBT-I or sleep apps should be con-
sidered, given the high likelihood of cost savings
and benefits of a non-face-to-face approach for
people with ASD and also in situations that restrict
a face-to-face consultation, such as pandemic.
Longitudinal research is required to inform the
adaptation of pharmacological and non-pharmaco-
logical sleep interventions to better meet the needs
of children and adults with ADHD or ASD and
their families (Martin 2019).
Clinical evaluations and management plans based
on comprehensive assessment and multidisciplinary
team evaluation, timely consultations with other
appropriate specialists in primary care, neurology
and respiratory medicine, and referral to specialist
sleep centres remain the mainstay in identifying
and managing sleep disorders in people with ASD
or ADHD.
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MCQs
Select the single best option for each question:
1 The prevalence of sleep disorders in adults






2 As regards the statement that delaying
treatment in adolescents with circadian
rhythm sleep–wake disorders is acceptable
as the sleep disorder will resolve in
adulthood:
a this is true only for those with ADHD
b this is true only for those with ASD
c this is true only for those without ADHD and ASD
d this is true
e this is false.
3 In advanced sleep–wake phase disorder,
use of a light box with 10 000 lux can be
considered:
a never
b at 03.00 h
c at 09.00 h
d at 15.00 h
e at 20.00 h.
4 As regards the prevalence of insomnia in
children and adults with ADHD:
a insomnia is not a reported sleep disorder in
children with ADHD
b the prevalence in adults is lower than the
prevalence in children
c the prevalence in adults is the same as the
prevalence in children
d the prevalence in adults is higher than the
prevalence in children
e insomnia is not a reported sleep disorder in
adults with ADHD.
5 The STOP-Bang Questionnaire is a widely
used screening tool for identifying:
a narcolepsy
b restless legs syndrome
c obstructive sleep apnoea
d parasomnias
e circadian rhythm sleep–wake disorders.
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